Special Issue "Cancer Immunotherapy: Tumor Microenvironment, Biomarker Discovery and Immune Resistance".

ABSTRACT

Since the launch of this Special Issue entitled "Cancer Immunotherapy Tumor Microenvironment, Biomarker Discovery and Immune Resistance", the field of cancer immunotherapy has continued to witness rapid growth in the development of novel agents, improvements in our understanding of mechanisms of response and resistance, and the maturation of emerging technologies such as artificial intelligence, machine learning, single-cell sequencing and spatial profiling [...].